Wilson Sonsini Goodrich & Rosati represented Ibotta in the offering, and Willkie Farr & Gallagher represented the underwriters. Ibotta (NYSE: IBTA), the digital marketing company backed...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised Montrose Environmental Group, Inc. on the offering, and Wilson Sonsini Goodrich & Rosati advised the underwriters. Montrose Environmental Group, Inc. (NYSE:...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Rubedo Life Sciences on the transaction. Rubedo Life Sciences (Rubedo), a biopharmaceutical company, announced it closed a $40M Series A...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Pantera Capital in the transaction. Mezo announced the closing of a $21 million fundraising led by Pantera Capital. Other investors in the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Mirage in the transaction. A generative AI company, Harvey announced the acquisition of Mirage. Following the acquisition, Mirage’s founders will...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Cobot on the transaction. Collaborative Robotics (Cobot), a leader in the development of practical collaborative robots, announced the completion of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Kumquat Biosciences on the transaction. Kumquat Biosciences, a leader in translating breakthrough science into first-in-class therapeutics, announced a strategic and...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented the investors in the transaction. D3 Bio, Inc, a clinical-stage biotechnology announced its closing of a $62 million Series A financing...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Kumquat Biosciences on the transaction. Kumquat Biosciences, a leader in translating breakthrough science into first-in-class therapeutics, announced a strategic and...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented the investors in the transaction. D3 Bio, Inc, a clinical-stage biotechnology announced its closing of a $62 million Series A financing...
You must be a Standard 1 Year member to access this content.
Cravath Swaine & Moore and Troutman Pepper Hamilton Sanders advised Albemarle Corporation on the offering, and Davis Polk & Wardwell advised the representatives of the several...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised investor Novo Holdings on the transaction. Obsidian Therapeutics, Inc. (Obsidian), a clinical-stage biotechnology company, announced it closed an oversubscribed $160.5...
You must be a Standard 1 Year member to access this content.
